Quantitative analysis of nailfold capillary abnormalities in patients with connective tissue diseases

Background Nailfold capillary microscopy has been shown to reflect microvascular disturbances mainly in connective tissue diseases including systemic sclerosis (SSc).

[1]  H. Maricq,et al.  Widefield capillary microscopy. technique and rating scale for abnormalities seen in scleroderma and related disorders , 1981 .

[2]  M. Jayson,et al.  Studies of the microvascular endothelium in uninvolved skin of patients with systemic sclerosis: direct evidence for a generalized microangiopathy , 1992, The British journal of dermatology.

[3]  M. Weinrich,et al.  Prevalence of Raynaud phenomenon in the general population. A preliminary study by questionnaire. , 1986, Journal of chronic diseases.

[4]  T. Medsger,et al.  Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. , 1988, Arthritis and rheumatism.

[5]  J. Schmidli,et al.  Quantitative nailfold capillary microscopy in cutaneous and systemic lupus erythematosus and localized and systemic scleroderma. , 1991, Journal of the American Academy of Dermatology.

[6]  D. Ubbink,et al.  Capillary Microscopy Is a Diagnostic Aid in Patients with Acral Ischemia , 1995, Angiology.

[7]  A. Hasegawa,et al.  Nailfold capillary abnormality and pulmonary hypertension in systemic sclerosis , 1997, International journal of dermatology.

[8]  J. F. Wolfe,et al.  Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. , 1980, Arthritis and rheumatism.

[9]  Gniadecka,et al.  Quantitative evaluation of chronological ageing and photoageing in vivo: studies on skin echogenicity and thickness , 1998, The British journal of dermatology.

[10]  P Lee,et al.  Nailfold capillary microscopy in the connective tissue diseases: a semiquantitative assessment. , 1983, The Journal of rheumatology.

[11]  A. Smit,et al.  Serial nailfold capillary microscopy in primary Raynaud's phenomenon and scleroderma. , 1994, Seminars in arthritis and rheumatism.

[12]  G. Spencer-Green.  Outcomes in primary Raynaud phenomenon: a meta-analysis of the frequency, rates, and predictors of transition to secondary diseases. , 1998, Archives of internal medicine.

[13]  M. Sackner,et al.  THE PATHOPHYSIOLOGY OF SCLERODERMA INVOLVING THE HEART AND RESPIRATORY SYSTEM. , 1964, Annals of internal medicine.

[14]  S. Calvieri,et al.  Relationship between cutaneous and pulmonary involvement in systemic sclerosis. , 1997, The Journal of rheumatology.

[15]  E F Ring,et al.  Quantitative nailfold capillaroscopy findings in a population with connective tissue disease and in normal healthy controls. , 1996, Annals of the rheumatic diseases.

[16]  E Mannarino,et al.  Nailfold Capillaroscopy in the Screening and Diagnosis of Raynaud's Phenomenon , 1994, Angiology.

[17]  H. Maricq,et al.  Skin capillary abnormalities as indicators of organ involvement in scleroderma (systemic sclerosis), Raynaud's syndrome and dermatomyositis. , 1976, The American journal of medicine.

[18]  F. Mearin,et al.  Survival prognostic factors and markers of morbidity in Spanish patients with systemic sclerosis , 1997, Annals of the rheumatic diseases.

[19]  E. Hess,et al.  Prospective study of the evolution of Raynaud's phenomenon. , 1988, The American journal of medicine.

[20]  M. Vayssairat,et al.  Raynaud's phenomenon together with antinuclear antibodies: a common subset of incomplete connective tissue disease. , 1995, Journal of the American Academy of Dermatology.

[21]  F Lefford,et al.  Nailfold capillary microscopy in connective tissue disease: a quantitative morphological analysis. , 1986, Annals of the rheumatic diseases.

[22]  T. The,et al.  Decreased nailfold capillary density in Raynaud's phenomenon: a reflection of immunologically mediated local and systemic vascular disease? , 1985, Annals of the rheumatic diseases.

[23]  M. Weinrich,et al.  Prevalence of scleroderma spectrum disorders in the general population of South Carolina. , 1989, Arthritis and rheumatism.

[24]  G. Spencer-Green,et al.  The evolution of Raynaud's phenomenon: a longterm prospective study. , 1995, The Journal of rheumatology.

[25]  E Michoud,et al.  Digitized nailfold capillaroscopy. , 1994, VASA. Zeitschrift fur Gefasskrankheiten.

[26]  Tamura,et al.  The predictive value of quantitative nailfold capillary microscopy in patients with undifferentiated connective tissue disease , 1998, The British journal of dermatology.

[27]  J. Piette,et al.  Antiendothelial cell antibodies: useful markers of systemic sclerosis. , 1997, The American journal of medicine.

[28]  R. Rogers,et al.  Pulmonary function in progressive systemic sclerosis. Comparison of CREST syndrome variant with diffuse scleroderma. , 1983, Chest.

[29]  D. Furst,et al.  Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis. , 1983, The American journal of medicine.

[30]  Image Analysis of Nailfold Capillaries in Patients with Undifferentiated Connective Tissue Syndromes , 1995, The Journal of dermatology.

[31]  Aaron Sloman,et al.  The evolution of what , 1998 .

[32]  C. Bucca,et al.  Exhaled nitric oxide and pulmonary response to iloprost in systemic sclerosis with pulmonary hypertension , 1998, The Lancet.

[33]  G. Alarcón,et al.  Early undifferentiated connective tissue disease. V. An inception cohort 5 years later: disease remissions and changes in diagnoses in well established and undifferentiated connective tissue diseases. , 1998, The Journal of rheumatology.

[34]  W Redisch,et al.  Classification and measurement of surface microvessels in man. , 1972, Microvascular research.

[35]  H. Maricq,et al.  Blind evaluation of the diagnostic specificity of nailfold capillary microscopy in the connective tissue diseases. , 1981, Arthritis and rheumatism.

[36]  P. Priollet,et al.  How to classify Raynaud's phenomenon. Long-term follow-up study of 73 cases. , 1987, The American journal of medicine.

[37]  H. Bogaars,et al.  The clinical significance of periodic acid-Schiff-positive deposits in cuticle-proximal nail fold biopsy specimens. , 1985, Archives of dermatology.

[38]  H. Maricq,et al.  A prospective study of Raynaud phenomenon and early connective tissue disease. A five-year report. , 1982, The American journal of medicine.

[39]  E. Tan,et al.  Microvascular abnormalities as possible predictors of disease subsets in Raynaud phenomenon and early connective tissue disease. , 1983, Clinical and experimental rheumatology.

[40]  C McEwen,et al.  Capillaroscopic observations in rheumatic diseases. , 1970, Annals of the rheumatic diseases.

[41]  C. Kallenberg,et al.  Pulmonary diffusing capacity disturbances are related to nailfold capillary changes in patients with Raynaud's phenomenon with and without an underlying connective tissue disease. , 1990, The American journal of medicine.